Keyphrases
Hypertension
100%
Endothelial Dysfunction
100%
Valsartan
100%
Randomized Double-blind Study
100%
Amlodipine
75%
Acetylcholine
50%
L-NMMA
50%
Nitric Oxide
37%
Vasodilator Responses
25%
Co-infusion
25%
Forearm
12%
Treatment Duration
12%
Placebo
12%
Endothelium-dependent
12%
Forearm Blood Flow
12%
Independent Pathway
12%
Arginine
12%
Angiotensin II Type 1 Receptor (AT1R)
12%
Hypertensive Subjects
12%
Nitric Oxide Release
12%
Placebo Run-in
12%
Bioactivity
12%
Intra-arterial Infusion
12%
Blood Pressure Control
12%
Ambulatory Blood Pressure
12%
Peripheral Endothelial Dysfunction
12%
Vasodilatory
12%
Resistance Arteries
12%
Angiotensin Type I Receptor
12%
Partial Effects
12%
Therapeutic Goals
12%
Cardiac Outcomes
12%
Clinical Blood Pressure
12%
Washout Period
12%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Dysfunction
100%
Valsartan
100%
Amlodipine
75%
Acetylcholine
50%
Nitric Oxide
50%
N(g) Methylarginine
50%
Placebo
25%
Arginine
12%
Scanning Electron Microscopy
12%
Angiotensin 1 Receptor
12%